Syncom Formulations (India) Balance Sheet Health
Financial Health criteria checks 5/6
Syncom Formulations (India) has a total shareholder equity of ₹2.7B and total debt of ₹800.9M, which brings its debt-to-equity ratio to 29.6%. Its total assets and total liabilities are ₹4.0B and ₹1.3B respectively. Syncom Formulations (India)'s EBIT is ₹217.2M making its interest coverage ratio 124.2. It has cash and short-term investments of ₹613.9M.
Key information
29.6%
Debt to equity ratio
₹800.90m
Debt
Interest coverage ratio | 124.2x |
Cash | ₹613.89m |
Equity | ₹2.70b |
Total liabilities | ₹1.34b |
Total assets | ₹4.04b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 524470's short term assets (₹1.9B) exceed its short term liabilities (₹1.2B).
Long Term Liabilities: 524470's short term assets (₹1.9B) exceed its long term liabilities (₹93.7M).
Debt to Equity History and Analysis
Debt Level: 524470's net debt to equity ratio (6.9%) is considered satisfactory.
Reducing Debt: 524470's debt to equity ratio has increased from 5.8% to 29.6% over the past 5 years.
Debt Coverage: 524470's debt is well covered by operating cash flow (21.2%).
Interest Coverage: 524470's interest payments on its debt are well covered by EBIT (124.2x coverage).